33,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
17 °P sammeln
  • Gebundenes Buch

Mehlman weighs the social and economic costs of the many proposals to regulate or limit genetic engineering and provides six concrete policy recommendations-from professional licensing to a ban on germ-line enhancement-that propose to make the future of genetic enhancement more equitable and safe.

Produktbeschreibung
Mehlman weighs the social and economic costs of the many proposals to regulate or limit genetic engineering and provides six concrete policy recommendations-from professional licensing to a ban on germ-line enhancement-that propose to make the future of genetic enhancement more equitable and safe.
Autorenporträt
Maxwell J. Mehlman is Arthur E. Petersilge Professor of Law and Director of the Law-Medicine Center, Case Western Reserve University School of Law, and Professor of Biomedical Ethics at the Case Western Reserve University School of Medicine. He is co-author of Access to the Genome: The Challenge to Equality and co-editor of the Encyclopedia of Ethical, Legal and Policy Issues in Biotechnology. He lives in Cleveland, Ohio.